Option Care Health, Inc. — Form 8-K
Filed July 29, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 38/100
What the filing says
Option Care Health reported Q2 2026 net revenue of $1,442M (+1.9% YoY), GAAP net income of $53.9M (+6.7%), and adjusted EBITDA of $117.5M (+3.0%). The company repurchased $150M in shares during Q2. Full-year 2026 guidance: revenue $5.675–$5.775B, adjusted EPS $1.85–$1.92, adjusted EBITDA $480–$495M. Q3 2026 expected to show low-to-mid single-digit sequential revenue growth and mid-single-digit adjusted EBITDA growth.
Why this rating
Modest organic revenue growth (1.9%) and slight margin expansion are routine operations. $150M buyback is 2.8% of market cap—meaningful but not transformational. Stable guidance reflects no material business inflection.
See more from July 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.